Myristoylation of viral and bacterial proteins

Trends in Microbiology

Volumn 12, Issue 4, 2004, Pages 178-185

  Maurer Stroh, Sebastian ^a   Eisenhaber, Frank ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GLYCINE; PROTEIN N MYRISTOYLTRANSFERASE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARENAVIRUS; DNA VIRUS; ENTOMOPOXVIRUS; ENZYME ACTIVITY; EUKARYOTIC CELL; FLAVIVIRUS; HOST CELL; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW; VIRUS ENVELOPE; VIRUS STRAIN;

ACYLTRANSFERASES; AMINO ACID SEQUENCE; ARENAVIRUS; BACTERIAL PROTEINS; DNA VIRUSES; FLAVIVIRUS; MOLECULAR SEQUENCE DATA; MYRISTATES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETROVIRIDAE; VIRAL PROTEINS;

ARENAVIRUS; BACTERIA (MICROORGANISMS); DNA VIRUSES; EUKARYOTA; FLAVIVIRUS; UNIDENTIFIED ENTOMOPOXVIRUS;

EID: 1642340046     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2004.02.006     Document Type: Review

References (79)

1. Maurer-Stroh S., et al. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence. J. Mol. Biol. 317:2002;541-557.
2. Eisenhaber F., et al. Prediction of lipid posttranslational modifications and localization signals from protein sequences: big-Pi, NMT and PTS1. Nucleic Acids Res. 31:2003;3631-3634.
3. Nimchuk Z., et al. Eukaryotic fatty acylation drives plasma membrane targeting and enhances function of several type III effector proteins from Pseudomonas syringae. Cell. 101:2000;353-363.
4. Farazi T.A., et al. The biology and enzymology of protein n-myristoylation. J. Biol. Chem. 276:2001;39501-39504.
5. Maurer-Stroh S., et al. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences. J. Mol. Biol. 317:2002;523-540.
6. Zha J., et al. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science. 290:2000;1761-1765.
7. Boisson B., et al. Unexpected protein families including cell defense components feature in the N-myristoylome of a higher eukaryote. J. Biol. Chem. 278:2003;43418-43429.
8. Zacharias D.A., et al. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science. 296:2002;913-916.
9. Hayashi N., et al. Nef of HIV-1 interacts directly with calcium-bound calmodulin. Protein Sci. 11:2002;529-537.
10. Liemann S., et al. Structure of the reovirus membrane-penetration protein, Mu1, in a complex with its protector protein, Sigma3. Cell. 108:2002;283-295.
11. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:2000;531-569.
12. Chandran K., Nibert M.L. Animal cell invasion by a large nonenveloped virus: reovirus delivers the goods. Trends Microbiol. 11:2003;374-382.
13. Cooper A., et al. The earliest steps in hepatitis B virus infection. Biochim. Biophys. Acta. 1614:2003;89-96.
14. Bruss V., et al. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity. Virology. 218:1996;396-399.
15. De Falco S., et al. N-terminal myristylation of HBV preS1 domain enhances receptor recognition. J. Pept. Res. 57:2001;390-400.
16. Dawe S., Duncan R. The S4 genome segment of baboon reovirus is bicistronic and encodes a novel fusion-associated small transmembrane protein. J. Virol. 76:2002;2131-2140.
17. Hogle J.M. Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu. Rev. Microbiol. 56:2002;677-702.
18. Chen X.S., et al. Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J. 17:1998;3233-3240.
19. Yahara T., et al. Molecular evolution of a host-range gene in geminiviruses infecting asexual populations of Eupatorium makinoi. Genes Genet. Syst. 73:1998;137-141.
20. Rojas M.R., et al. Functional analysis of proteins involved in movement of the monopartite begomovirus, Tomato yellow leaf curl virus. Virology. 291:2001;110-125.
21. Greenway A.L., et al. HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication. J. Biosci. 28:2003;311-321.
22. Scarlata S., Carter C. Role of HIV-1 Gag domains in viral assembly. Biochim. Biophys. Acta. 1614:2003;62-72.
23. Lindwasser O.W., Resh M.D. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75:2001;7913-7924.
24. Hermida-Matsumoto L., Resh M.D. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55 (gag) and p17MA. J. Virol. 73:1999;1902-1908.
25. Dupont S., et al. A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature. 402:1999;681-685.
26. Schultz A., Oroszlan S. Myristylation of gag-onc fusion proteins in mammalian transforming retroviruses. Virology. 133:1984;431-437.
27. Jotte R.M., Holt J.T. Myristylation of FBR v-fos dictates the differentiation pathways in malignant osteosarcoma. J. Cell Biol. 135:1996;457-467.
28. Rasheed S., et al. Nucleotide sequence of the Rasheed rat sarcoma virus oncogene: new mutations. Science. 221:1983;155-157.
29. Reddy E.P., et al. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc. Natl. Acad. Sci. U. S. A. 80:1983;3623-3627.
30. Eves E.M., et al. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol. Cell. Biol. 18:1998;2143-2152.
31. Baker S.J., et al. The role of v-Fgr myristoylation and the Gag domain in membrane binding and cellular transformation. Virology. 249:1998;1-11.
32. Gallick G.E., Arlinghaus R.B. Incorporation of lipids into variants of Moloney sarcoma virus which produce gag-mos fusion proteins. Virology. 133:1984;228-232.
33. Frame M.C., et al. v-Src's hold over actin and cell adhesions. Nat. Rev. Mol. Cell Biol. 3:2002;233-245.
34. Hantschel O., et al. A myristoyl/phosphotyrosine switch regulates c-Abl. Cell. 112:2003;845-857.
35. Cobbold C., et al. Biochemical requirements of virus wrapping by the endoplasmic reticulum: involvement of ATP and endoplasmic reticulum calcium store during envelopment of African swine fever virus. J. Virol. 74:2000;2151-2160.
36. Ravanello M.P., Hruby D.E. Characterization of the vaccinia virus L1R myristyl protein as a component of the intracellular virion envelope. J. Gen. Virol. 75:1994;1479-1483.
37. Senkevich T.G., et al. Complete pathway for protein disulfide bond formation encoded by poxviruses. Proc. Natl. Acad. Sci. U. S. A. 99:2002;6667-6672.
38. Iyer L.M., et al. Common origin of four diverse families of large eukaryotic DNA viruses. J. Virol. 75:2001;11720-11734.
39. Granzow H., et al. Ultrastructural analysis of the replication cycle of pseudorabies virus in cell culture: a reassessment. J. Virol. 71:1997;2072-2082.
40. Loomis J.S., et al. Intracellular trafficking of the UL11 tegument protein of herpes simplex virus type 1. J. Virol. 75:2001;12209-12219.
41. Sanchez V., et al. Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi- intermediate compartment. J. Virol. 74:2000;3842-3851.
42. Fraefel C., et al. Immediate-early transcription over covalently joined genome ends of bovine herpesvirus 1: the circ gene. J. Virol. 67:1993;1328-1333.
43. Cheung A.K. Cloning of the latency gene and the early protein 0 gene of pseudorabies virus. J. Virol. 65:1991;5260-5271.
44. Grosenbach D.W., Hruby D.E. Biology of vaccinia virus acylproteins. Front. Biosci. 3:1998;d354-d364.
45. Rodriguez J.R., et al. Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J. Virol. 71:1997;1821-1833.
46. Martin K.H., et al. Identification and analysis of three myristylated vaccinia virus late proteins. J. Virol. 71:1997;5218-5226.
47. Blake N.W., et al. Characterization of a molluscum contagiosum virus homolog of the vaccinia virus p37K major envelope antigen. J. Virol. 65:1991;3583-3589.
48. Grosenbach D.W., Hruby D.E. Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment. J. Virol. 72:1998;5108-5120.
49. Cordo S.M., et al. Myristic acid analogs are inhibitors of Junin virus replication. Microbes Infect. 1:1999;609-614.
50. Cornu T.I., de la Torre J.C. Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis. J. Virol. 76:2002;6678-6688.
51. Zhang L., et al. Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5. J. Virol. 66:1992;7549-7554.
52. Uchil P.D., Satchidanandam V. Architecture of the flaviviral replication complex: protease, nuclease and detergents reveal encasement within double-layered membrane compartments. J. Biol. Chem. 278:2003;24388-24398.
53. Egloff M.P., et al. An RNA cap (nucleoside-2′-O-) -methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J. 21:2002;2757-2768.
54. Guyatt K.J., et al. Expression and purification of enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the flavivirus Kunjin. J. Virol. Methods. 92:2001;37-44.
55. Thomas N.A., Brett F.B. Establishing order for type III secretion substrates - a hierarchical process. Trends Microbiol. 11:2003;398-403.
56. Guttman D.S., et al. A functional screen for the type III (Hrp) secretome of the plant pathogen Pseudomonas syringae. Science. 295:2002;1722-1726.
57. Petnicki-Ocwieja T., et al. Genome wide identification of proteins secreted by the Hrp type III protein secretion system of Pseudomonas syringae pv. tomato DC3000. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7652-7657.
58. Collmer A., et al. Genomic mining type III secretion system effectors in Pseudomonas syringae yields new picks for all TTSS prospectors. Trends Microbiol. 10:2002;462-469.
59. McGuinness D.H., et al. Pattern recognition molecules and innate immunity to parasites. Trends Parasitol. 19:2003;312-319.
60. Bryant M.L., et al. Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid. Proc. Natl. Acad. Sci. U. S. A. 86:1989;8655-8659.
61. Parang K., et al. In vitro antiviral activities of myristic acid analogs against human immunodeficiency and hepatitis B viruses. Antiviral Res. 34:1997;75-90.
62. Harper D.R., et al. Inhibition of varicella-zoster virus replication by an inhibitor of protein myristoylation. J. Gen. Virol. 74:1993;1181-1184.
63. Cserzo M., et al. On filtering false positive transmembrane protein predictions. Protein Eng. 15:2002;745-752.
64. Yu G., Felsted R.L. Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. Virology. 187:1992;46-55.
65. Ono A., Freed E.O. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73:1999;4136-4144.
66. Rein A., et al. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 83:1986;7246-7250.
67. Hizi A., et al. Analysis of gag proteins from mouse mammary tumor virus. J. Virol. 63:1989;2543-2549.
68. 2-terminal myristoylated proteins in the retrovirus-infected cells. Biochem. Biophys. Res. Commun. 162:1989;724-732.
69. Moscufo N., et al. Myristoylation is important at multiple stages in poliovirus assembly. J. Virol. 65:1991;2372-2380.
70. Gripon P., et al. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology. 213:1995;292-299.
71. 2-terminal peptide from the vaccinia virus L1R protein directs the myristylation and virion envelope localization of a heterologous fusion protein. J. Biol. Chem. 268:1993;7585-7593.
72. Resh M.D. Myristylation and palmitylation of Src family members: the fats of the matter. Cell. 76:1994;411-413.
73. Streuli C.H., Griffin B.E. Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature. 326:1987;619-622.
74. MacLean C.A., et al. The myristylated virion proteins of herpes simplex virus type 1: investigation of their role in the virus life cycle. J. Gen. Virol. 73:1992;539-547.
75. Tillotson L., Shatkin A.J. Reovirus polypeptide sigma 3 and N-terminal myristoylation of polypeptide mu 1 are required for site-specific cleavage to mu 1C in transfected cells. J. Virol. 66:1992;2180-2186.
76. Simon-Mateo C., et al. Polyprotein processing in African swine fever virus: a novel gene expression strategy for a DNA virus. EMBO J. 12:1993;2977-2987.
77. Shan L., et al. The pseudomonas AvrPto protein is differentially recognized by tomato and tobacco and is localized to the plant plasma membrane. Plant Cell. 12:2000;2323-2338.
78. van Dijk K., et al. The Avr (effector) proteins HrmA (HopPsyA) and AvrPto are secreted in culture from Pseudomonas syringae pathovars via the Hrp (type III) protein secretion system in a temperature- and pH-sensitive manner. J. Bacteriol. 181:1999;4790-4797.
79. Menard R., et al. The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. EMBO J. 13:1994;5293-5302.